Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COL1A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | JOSD2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PRIMPOL | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | CRELD1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | RPS28 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | DDHD2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | LRP5L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | APEX1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SEPT8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ANXA9 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |